Your browser doesn't support javascript.
loading
Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Grimm, Sabine E; Fayter, Debra; Ramaekers, Bram L T; Petersohn, Svenja; Riemsma, Rob; Armstrong, Nigel; Pouwels, Xavier; Witlox, Willem; Noake, Caro; Worthy, Gillian; Kleijnen, Jos; Joore, Manuela A.
Afiliação
  • Grimm SE; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands. Sabine.grimm@mumc.nl.
  • Fayter D; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Ramaekers BLT; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
  • Petersohn S; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
  • Riemsma R; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Armstrong N; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Pouwels X; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
  • Witlox W; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
  • Noake C; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Worthy G; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Kleijnen J; Kleijnen Systematic Reviews Ltd, 6 Escrick Business Park, Riccall Road, York, YO19 6FD, UK.
  • Joore MA; Department of Clinical Epidemiology and Medical Technology Assessment, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, The Netherlands.
Pharmacoeconomics ; 37(10): 1195-1207, 2019 10.
Article em En | MEDLINE | ID: mdl-30895564
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Health_technology_assessment / Observational_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Health_technology_assessment / Observational_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Pharmacoeconomics Ano de publicação: 2019 Tipo de documento: Article